Abstract
In the last decade mass screening strategies became the main source of leads in drug discovery settings. Although high throughput (HTS) and virtual screening (VS) realize the same concept the different nature of these lead discovery strategies (experimental vs theoretical) results that they are typically applied separately. The majority of drug leads are still identified by hit-to-lead optimization of screening hits. Structural information on the target as well as on bound ligands, however, make structure-based and ligand-based virtual screening available for the identification of alternative chemical starting points. Although, the two techniques have rarely been used together on the same target, here we review the existing prominent studies on their true integration. Various approaches have been shown to apply the combination of HTS and VS and to better use them in lead generation. Although several attempts on their integration have only been considered at a conceptual level, there are numerous applications underlining its relevance that early-stage pharmaceutical drug research could benefit from a combined approach.
Keywords: Virtual screening, high throughput screening, integration, parallel screening, focused screening, sequential screening, Lead Discovery, biological activity
Combinatorial Chemistry & High Throughput Screening
Title: Integration of Virtual and High Throughput Screening in Lead Discovery Settings
Volume: 14 Issue: 10
Author(s): Timea Polgar and Gyorgy M. Keseru
Affiliation:
Keywords: Virtual screening, high throughput screening, integration, parallel screening, focused screening, sequential screening, Lead Discovery, biological activity
Abstract: In the last decade mass screening strategies became the main source of leads in drug discovery settings. Although high throughput (HTS) and virtual screening (VS) realize the same concept the different nature of these lead discovery strategies (experimental vs theoretical) results that they are typically applied separately. The majority of drug leads are still identified by hit-to-lead optimization of screening hits. Structural information on the target as well as on bound ligands, however, make structure-based and ligand-based virtual screening available for the identification of alternative chemical starting points. Although, the two techniques have rarely been used together on the same target, here we review the existing prominent studies on their true integration. Various approaches have been shown to apply the combination of HTS and VS and to better use them in lead generation. Although several attempts on their integration have only been considered at a conceptual level, there are numerous applications underlining its relevance that early-stage pharmaceutical drug research could benefit from a combined approach.
Export Options
About this article
Cite this article as:
Polgar Timea and M. Keseru Gyorgy, Integration of Virtual and High Throughput Screening in Lead Discovery Settings, Combinatorial Chemistry & High Throughput Screening 2011; 14 (10) . https://dx.doi.org/10.2174/138620711797537148
DOI https://dx.doi.org/10.2174/138620711797537148 |
Print ISSN 1386-2073 |
Publisher Name Bentham Science Publisher |
Online ISSN 1875-5402 |
- Author Guidelines
- Graphical Abstracts
- Fabricating and Stating False Information
- Research Misconduct
- Post Publication Discussions and Corrections
- Publishing Ethics and Rectitude
- Increase Visibility of Your Article
- Archiving Policies
- Peer Review Workflow
- Order Your Article Before Print
- Promote Your Article
- Manuscript Transfer Facility
- Editorial Policies
- Allegations from Whistleblowers
Related Articles
-
Drug Repurposing: An Emerging Tool for Drug Reuse, Recycling and Discovery
Current Drug Research Reviews Antioxidant Therapy Alters Brain MAPK-JNK and BDNF Signaling Path-ways in Experimental Diabetes Mellitu s
Current Neurovascular Research Non-Linear Alteration of Serotonin Transport Availability in Posttraumatic Stress Disorder Measured with 4-[<sup>18</sup>F] ADAM Positron Emission Tomography
Current Molecular Imaging (Discontinued) Author Index To Volume 5
CNS & Neurological Disorders - Drug Targets Prospects for miR-21 as a Target in the Treatment of Lung Diseases
Current Pharmaceutical Design Using WPNNA Classifier in Ubiquitination Site Prediction Based on Hybrid Features
Protein & Peptide Letters Editorial: Drug Targets and Biomarkers for Obstetric/Gynecologic/Reproductive Diseases
Current Drug Targets Expression and Function of PPARs in Cancer Stem Cells
Current Stem Cell Research & Therapy MicroRNA Expression Levels in Patients with Hashimoto Thyroiditis: A Single Centre Study
Endocrine, Metabolic & Immune Disorders - Drug Targets Meet Our Editorial Board Member
Current Medicinal Chemistry Docking Investigation on Bis (Nitro Indazolyl) Methanes; Synthesis and Antimicrobial Activity Towards Breast Cancer Applications
Letters in Organic Chemistry Antibody Delivery Mediated by Recombinant Adeno-associated Virus for the Treatment of Various Chronic and Infectious Diseases
Current Gene Therapy In-vitro Evaluation of Transungual Formulation of Ketoconazole for the Management of Onychomycosis
Drug Delivery Letters A Critical Analysis of the Utility and Compatibility of Motivation Theories in Psychiatric Treatment
Current Psychiatry Reviews Endocrine Therapies and QTc Prolongation
Current Drug Safety The Pharmacology of Human Appetite Expression
Current Drug Targets Nanoparticle Delivery of Transition-Metal Chelators to the Brain: Oxidative Stress will Never See it Coming!
CNS & Neurological Disorders - Drug Targets Pharmacodynamic Studies of Chinese Medicine at Levels of Whole Animal, Cell and Molecular Models
Current Medicinal Chemistry Synthetic Applications of Enzymes Entrapped in Reverse Micelles & Organo-GelsΨ
Current Organic Chemistry Conformations and Biological Activities of Amyloid Beta Peptide 25-35
Current Protein & Peptide Science